NCT02158078View on ClinicalTrials.gov

A Prospective Observational Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus

TerminatedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Type 2 Diabetes Mellitus
Interventions
DEVICE

PaQ® Insulin Delivery Device

PaQ is a 3 day insulin delivery device. Utilizes U 100 rapid-acting insulin. Provides basal insulin at preset basal doses and bolus insulin (in 2 unit increments) with a push of a button.

Trial Locations (1)

A-8036

Medical University of Graz, Graz

Sponsors

Lead Sponsor

CeQur Corporation
All Listed Sponsors
lead

CeQur Corporation

INDUSTRY